BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15808566)

  • 21. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolongation of rat heart allografts by donor-specific blood transfusion treated with ultraviolet irradiation.
    Oluwole SF; Iga C; Lau H; Hardy MA
    J Heart Transplant; 1985; 4(4):385-9. PubMed ID: 2956395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins induce immunosuppressive effect on heterotopic limb allografts in rat through inhibiting T cell activation and proliferation.
    Nie C; Yang D; Liu G; Dong D; Ma Z; Fu H; Zhao Z; Sun Z
    Eur J Pharmacol; 2009 Jan; 602(1):168-75. PubMed ID: 19041862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged heart allograft survival resulted from donor-specific T-cell sequestering and removal by selective splenectomy in mice.
    Zhu XH; Chen S; Chen ZK
    Transplant Proc; 2004 Oct; 36(8):2448-9. PubMed ID: 15561276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of T suppressor cells on the maintenance phase of tolerance to cardiac allografts in the rats].
    Guo HW; Wu QY; Xie SS; Zhang QY
    Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(16):980-3. PubMed ID: 15363234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infectious tolerance develops after intrathymic alloantigen-induced acceptance of rat heart allografts can be adoptively transferred.
    Takayashiki T; Asakura H; Ku G; Kataoka M; Flye MW
    Surgery; 2005 Aug; 138(2):254-60. PubMed ID: 16153434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 15AU81, a prostacyclin analog, enhances donor-specific hepatocytes to prolong the survival of rat heart but not small bowel allografts.
    Boyle MJ; Dumble LJ
    Cell Transplant; 1999; 8(5):543-8. PubMed ID: 10580348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administration of antisense oligodeoxyribonucleotides targeting NF-kappaB prolongs allograft survival via suppression of cytotoxicity.
    Chen Z; Lu L; Zhang H; Dean NM; Fung JJ; Qian S
    Microsurgery; 2003; 23(5):494-7. PubMed ID: 14558009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allochimeric therapy induces unique regulatory T cells that mitigate chronic rejection.
    Semiletova NV; Shen XD; Slomowitz SJ; Baibakov B; Feldman DM; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
    Transplant Proc; 2005; 37(1):35-6. PubMed ID: 15808538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A combination of donor specific transfusion and rapamycin prolongs cardiac allograft survival in mice.
    Wu K; Xiang F; Yuan J; Zeng Z; Zhou H; Chang S; Chen ZK
    Transplant Proc; 2008 Dec; 40(10):3699-701. PubMed ID: 19100468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
    Deuse T; Schrepfer S; Pelletier MP; Fischbein MP; Robbins RC; Reichenspurner H
    Transplant Proc; 2007 Mar; 39(2):569-72. PubMed ID: 17362784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolongation of survival of fully allogeneic cardiac grafts and generation of regulatory cells by a histamine receptor 2 antagonist.
    Inoue F; Zhang Q; Akiyoshi T; Aramaki O; Iwami D; Matsumoto K; Kitagawa Y; Shirasugi N; Niimi M
    Transplantation; 2007 Nov; 84(10):1288-97. PubMed ID: 18049114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta/interleukin-2-induced regulatory CD4+ T cells prolong cardiac allograft survival in rats.
    Watanabe M; Mencel RL; Cramer DV; Starnes VA; Barr ML
    J Heart Lung Transplant; 2005 Dec; 24(12):2153-9. PubMed ID: 16364865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic T-cell apoptosis induced by interleukin-10-modified dendritic cells: a mechanism of prolongation of intestine allograft survival?
    Zhu M; Wei MF; Liu F; Shi HF; Wang G; Chen S
    Transplant Proc; 2004 Oct; 36(8):2436-7. PubMed ID: 15561271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced cardiac allograft survival by Vav1-Rac signaling blockade in a mouse model.
    Wang S; Diao H; Guan Q; Jevnikar AM; Du C
    Transpl Immunol; 2007 Jul; 18(1):53-61. PubMed ID: 17584603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart allograft acceptance induced by anti-CD3 antibody in high-responder rats: effect on foxp3 and cytokine expression and graft infiltration.
    Lam VW; Taylor CF; Laurence JM; Wang C; Sharland AF; McCaughan GW; Hodgkinson S; Allen RD; Hall BM; Bishop GA
    Transpl Immunol; 2008 Apr; 19(1):20-4. PubMed ID: 18346633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of T-cell response and prolongation of allograft survival in a rat model by tryptophan catabolites.
    Dai X; Zhu BT
    Eur J Pharmacol; 2009 Mar; 606(1-3):225-32. PubMed ID: 19374879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gramicidin as a potential immunosuppressant for organ transplantation: suppression of human lymphocyte blastogenesis in vitro and prolongation of heart allograft survival in the rat.
    Hirano T; Oka K; Tamaki T
    J Pharmacol Exp Ther; 1995 Apr; 273(1):223-9. PubMed ID: 7536243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathymic injection of allogeneic cells induces indefinite survival of cardiac but not small bowel grafts.
    Xia W; Sayegh MH; Kirkman RL
    Transplant Proc; 1994 Jun; 26(3):1581. PubMed ID: 8030045
    [No Abstract]   [Full Text] [Related]  

  • 40. Sirolimus-mediated prolongation of rat cardiac allograft survival is enhanced by beta1 integrin very late antigen-4 blockade.
    Vu MD; Qi S; Sehgal SN; Chen H; Kennedy JD
    Transplant Proc; 2005; 37(1):162-3. PubMed ID: 15808581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.